The Dried Bloodspot Collection Card Market is expected to register a CAGR of 4.7% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Card Type (Ahlstrom 226, Whatman 903, FTA, and Others). The report further presents analysis based on the Application (Infectious Disease Testing, Newborn Screening, Forensics, Therapeutic Drug Monitoring, and Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Dried Bloodspot Collection Card Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Dried Bloodspot Collection Card Market Segmentation
Card Type- Ahlstrom 226
- Whatman 903
- FTA
- Infectious Disease Testing
- Newborn Screening
- Forensics
- Therapeutic Drug Monitoring
Strategic Insights
Dried Bloodspot Collection Card Market Growth Drivers- Advancements in Diagnostic Testing: Dried bloodspot collection cards (DBS) are increasingly used in point-of-care diagnostics. These cards simplify blood sample collection and storage, providing an affordable, non-invasive alternative for disease detection and monitoring. The growing demand for accurate, rapid diagnostics across various diseases is driving the DBS market, especially in resource-limited settings where traditional lab-based testing may not be feasible.
- Growth in Home Healthcare: The rise of home healthcare services, including telemedicine, has accelerated the adoption of DBS collection cards. These cards enable at-home blood collection, enhancing patient convenience and compliance with healthcare regimens. Additionally, they are used in newborn screening and chronic disease monitoring, especially for diabetes and genetic disorders, thus driving the market’s expansion in personal health monitoring solutions.
- Government Initiatives for Disease Surveillance: Governments across the world are leveraging DBS collection cards for large-scale disease surveillance, particularly in global health emergencies. The use of DBS cards in detecting infectious diseases, including HIV, malaria, and hepatitis, is expanding. These cards help streamline data collection and provide more accessible, cost-effective testing solutions for epidemic control, fueling their growing adoption in public health initiatives.
- Integration with Digital Health Platforms: DBS collection cards are increasingly being integrated with digital health technologies, such as mobile apps and cloud-based platforms, to enable remote monitoring and diagnosis. This trend is driving the development of smart DBS cards that can transmit results directly to healthcare providers, enhancing efficiency, accuracy, and convenience for both patients and clinicians in managing chronic conditions and infectious diseases.
- Miniaturization of DBS Cards: The miniaturization of DBS cards is another growing trend. With more compact and easy-to-use designs, these collection cards are becoming even more practical for patients and healthcare workers. Small, portable devices enable more convenient and frequent sample collection, particularly for at-home testing and fieldwork in remote or underserved regions, increasing accessibility and reducing barriers to healthcare.
- Rising Popularity in Personalized Medicine: The demand for personalized medicine has led to an increase in the use of DBS collection cards for genetic testing and disease prevention. Their ability to efficiently collect DNA and biomarker samples in a non-invasive manner makes them ideal for personalized diagnostic applications, including pharmacogenomic testing and tailored treatment plans for chronic diseases, which are becoming more prevalent in the healthcare industry.
- Expanding Applications in Disease Monitoring: DBS cards present a significant opportunity for expanding applications in disease monitoring, particularly for chronic diseases like diabetes, cardiovascular conditions, and genetic disorders. The cards provide a cost-effective way to track biomarkers and make regular health assessments more accessible, creating opportunities for widespread adoption in routine healthcare settings and clinical trials.
- Emerging Markets Adoption: Emerging markets with limited access to traditional healthcare infrastructure offer growth opportunities for the DBS collection card market. Their low-cost, portable, and easy-to-use nature makes DBS cards ideal for diagnostic applications in these regions. The growing focus on improving healthcare access in underserved areas provides a clear path for expanding market reach in these regions.
- Development of New Testing Methods: New testing methods and innovations in biomarkers are creating opportunities for DBS collection cards in new areas such as cancer diagnostics, infectious disease detection, and prenatal testing. As research in these fields advances, the potential for DBS cards to be used in more precise and diverse diagnostic applications is growing, leading to further market expansion.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Dried Bloodspot Collection Card Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Dried Bloodspot Collection Card Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Advances in diagnostic testing, growth in home healthcare, and government disease surveillance initiatives are the primary drivers of the market.
Digital health platforms enable real-time data transmission and remote monitoring, improving patient convenience and increasing DBS card adoption in diagnostics.
Regulatory challenges, technological integration issues, and the need for standardized testing methods pose significant hurdles for the market.
Emerging economies offer substantial growth potential due to the increasing need for affordable, accessible healthcare solutions.
Healthcare diagnostics, newborn screening, pharmaceutical companies, and academic research are the main sectors adopting DBS collection cards.
DBS cards allow non-invasive sample collection for genetic testing and pharmacogenomics, supporting personalized treatment strategies.
- Thermo Fisher Scientific
- PerkinElmer
- F. Hoffmann-La Roche
- Abbott Laboratories
- Bio-Rad Laboratories
- Neogen Corporation
- GFE GmbH
- Enzo Biochem
- Scisco
- Sanguine BioSciences
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For